Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples

2 Oct 2018

Abstract excerpt

Aims Following the development for liquid biopsies of the SiRe next-generation sequencing (NGS) panel that covers 568 clinical relevant mutations in EGFR, KRAS, NRAS, BRAF, cKIT and PDGFRa genes, in this current study, we apply this small NGS panel on tissue samples of lung cancer. Methods A total of 322 specimens were prospectively tested. Technical parameters were analysed on both cytological and histological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to Molecular Biology Techniques and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30279174
DOI: 10.1136/jclinpath-2018-205386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samplesPMID 30279174Read ↗

Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal settingSemantic proximity Read ↗

Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.Semantic proximity Read ↗

Technical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study.Semantic proximity Read ↗

Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study.Semantic proximity Read ↗

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung CancerSemantic proximity Read ↗

TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study.Semantic proximity Read ↗

The relevance of the reference range for EGFR testing in non-small cell lung cancer patients.Semantic proximity Read ↗

Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: a retrospective study.Semantic proximity Read ↗

Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing.Semantic proximity Read ↗

Quality metrics for enhanced performance of an NGS panel using single-vial amplification technology.Semantic proximity Read ↗

Deep ion sequencing of amplicon adapter ligated libraries: a novel tool in molecular diagnostics of formalin fixed and paraffin embedded tissues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.